NEW YORK, August 21, 2017 /PRNewswire/ --
If you want a Stock Review on STE, ARAY, NUVA, or NVCR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Friday, August 18, 2017, major US indices were bearish at the close of Friday's session. The NASDAQ Composite ended the day at 6,216.53, down 0.09%; the Dow Jones Industrial Average edged 0.35% lower, to finish at 21,674.51; and the S&P 500 closed at 2,425.55, down 0.18%. 3 out of 9 sectors closed in green, 4 sectors finished in red, and 2 sector ended flat for the day. This Monday morning, DailyStockTracker.com looks at the performance of these four Medical Appliances & Equipment stocks: Steris PLC (NYSE: STE), Accuray Inc. (NASDAQ: ARAY), NuVasive Inc. (NASDAQ: NUVA), and NovoCure Ltd (NASDAQ: NVCR). This morning's free research reports on the aforesaid equities can be accessed upon registration on DailyStockTracker.com at:
Leicester, the UK headquartered Steris PLC's stock saw a drop of 1.28%, finishing last Friday's trading session at $85.13. A total volume of 392,094 shares was traded. The Company's shares have gained 12.64% over the previous three months, 19.90% in the past twelve months, and 26.32% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 3.17% and 16.35%, respectively. Additionally, shares of Steris, which develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide, have a Relative Strength Index (RSI) of 56.55. Visit us today and download your complete report on STE for free at:
Shares in Sunnyvale, California headquartered Accuray Inc. ended the session flat at $4.05. The stock recorded a trading volume of 398,522 shares. The Company's shares have advanced 1.25% over the previous three months. The stock is trading below its 50-day moving average by 7.96%. Moreover, shares of Accuray, which designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body, have an RSI of 41.81. The complimentary research report on ARAY can be accessed at:
On Friday, shares in San Diego, California headquartered NuVasive Inc. recorded a trading volume of 1.06 million shares, which was above their three months average volume of 924.03 thousand shares. The stock declined 2.84%, closing the day at $64.06. The Company's shares have gained 1.73% in the past twelve months. The stock is trading below its 50-day moving average by 13.68%. Additionally, shares of NuVasive, which develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery, have an RSI of 34.15.
On July 28th, 2017, research firm Robert W. Baird downgraded the Company's stock rating from 'Outperform' to 'Neutral' while revising its previous target price from $79 a share to $72 a share. Register for free on DailyStockTracker.com and download the research report on NUVA at:
At the close of trading on Friday, shares in Saint Helier, the Channel Islands-based NovoCure Ltd recorded a trading volume of 860,903 shares. The stock finished the session 2.08% lower at $18.85. The Company's shares have gained 63.20% in the previous three months, 135.04% over the past twelve months, and 140.13% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 4.66% and 68.40%, respectively. Furthermore, shares of NovoCure, which engages in the development, manufacture, and commercialization of tumor treating fields for the treatment of solid tumors, have an RSI of 49.59. Get free access to your research report on NVCR at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA